BC
ETNB

Bridgefront Capital’s 89bio ETNB Stock Holding History

Bridgefront Capital’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,261
Closed -$166K – 539
2024
Q1 		$166K Buy
+14,261
New +$158K 0.13% 328

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridgefront Capital's ETNB Position: Q2 2024 in Review

Bridgefront Capital sold out of 89bio (ETNB) in Q2 2024, closing a stake of 14,261 shares — an estimated $166K sold.

Bridgefront Capital first reported a position in ETNB in Q1 2024 and held it in 1 quarter. The position peaked at $166K in Q1 2024. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • Bridgefront Capital reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • Bridgefront Capital sold 14,261 89bio shares in Q2 2024, an estimated $166K.
  • Bridgefront Capital first reported a position in 89bio in Q1 2024 and held it in 1 quarter.
  • Bridgefront Capital's 89bio position peaked at $166K in Q1 2024.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on Bridgefront Capital's 13F filing for Q2 2024, filed 14 Aug 2024.